Dividend-Stock Deep Dive: Drugmakers
Morningstar's sector director discusses dividend growth and our favorite dividend payers in the industry.
David Harrell: I'm David Harrell, editor of Morningstar DividendInvestor. Like many of you, I'm interested in stocks with durable dividends. So, there's a recent piece of research from Morningstar's healthcare analysts about biopharma firms that caught my eye, in part because the title included the phrase "secure dividend growth." So, I've invited the lead author of that report to join me to talk about that research today.
Damien, thanks for being here.